The suit alleges the Seattle-based biotech misled investors regarding its funds and the effectiveness of some of its ...

These roles are especially challenging for women, who are rare at corporate helms, particularly in the two-decade-old biotechnology industry. As biotech matures, the percentage of women at the top is ...

Since its peak in 2021, VC funding for women-led ventures has struggled to remain consistent. However, deal value rebounded in 2024, and the deal count continued on its downward trend from 2021.